Neoadjuvant Therapy With Toripalimab and JS004 Combined With Platinum-based Doublet Chemotherapy for Resectable or Potentially Resectable Stage III Non-small Cell Lung Cancer: A Randomised Controlled, Open-label, Phase 2 Trial
Clinical trial NCT05891080 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT05891080
- Sponsor
- Shanghai Pulmonary Hospital, Shanghai, China
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-07-01
- Primary completion
- 2025-07-01
- Enrollment
- 124
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.